Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SABI Mind is a Canadian private mental health and chronic pain clinic company focused on ketamine-assisted therapy, psychedelic-assisted psychotherapy, intravenous and intramuscular ketamine treatment, and rTMS-based mental wellness services. The company operates healing centres in Calgary and Victoria and positions itself as a client-centered provider for patients who have not found adequate benefit from conventional care. In addition to direct clinical services, SABI Mind has described itself as a research organization and has participated in psychedelic-related survey and research initiatives. Its service model emphasizes a structured care pathway of preparation, discovery, and integration, combining medical oversight with psychotherapy and supportive care. The company appears to be a healthcare delivery organization rather than a drug-development biotech with a traditional therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SABI Mind.